May 11, 2018 / 11:10 AM / 14 days ago

BRIEF-Oncolytics Biotech Reports Qtrly Basic And Diluted Loss Per Common Share Of $0.03

May 11 (Reuters) - Oncolytics Biotech Inc:

* ONCOLYTICS BIOTECH® REPORTS 2018 FIRST QUARTER RESULTS

* ONCOLYTICS BIOTECH INC - QTRLY BASIC AND DILUTED LOSS PER COMMON SHARE $0.03

* ONCOLYTICS BIOTECH INC - AT MARCH 31, 2018, CO REPORTED $7.7 MILLION IN CASH AND CASH EQUIVALENTS

* ONCOLYTICS BIOTECH INC - ALL DOLLAR AMOUNTS ARE CANADIAN

* ONCOLYTICS - ADVANCED PLANS TO RELIST CO’S SHARES ON NASDAQ CAPITAL MARKET EXCHANGE, CONTINUES TO EVALUATE TIMING OF THIS ACTION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below